ChemSpider 2D Image | atracurium besylate | C65H82N2O18S2

atracurium besylate

  • Molecular FormulaC65H82N2O18S2
  • Average mass1243.479 Da
  • Monoisotopic mass1242.500366 Da
  • ChemSpider ID43068
  • Charge - Charge


More details:



Featured data source



Validated by Experts, Validated by Users, Non-Validated, Removed by Users

2,2'-{1,5-Pentandiylbis[oxy(3-oxo-3,1-propandiyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisochinolinium]dibenzolsulfonat [German] [ACD/IUPAC Name]
2,2'-{1,5-Pentanediylbis[oxy(3-oxo-3,1-propanediyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate [ACD/IUPAC Name]
2,2'-{Pentan-1,5-diylbis[oxy(3-oxopropan-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisochinolinium]bisbenzolsulfonat
2,2'-{Pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-(3,4-dimethoxybenzyl)-6,7-dimethoxy-2-methyl-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate
2,2'-{pentane-1,5-diylbis[oxy(3-oxopropane-3,1-diyl)]}bis[1-{[3,4-bis(methyloxy)phenyl]methyl}-2-methyl-6,7-bis(methyloxy)-1,2,3,4-tetrahydroisoquinolinium] bisbenzenesulfonate
264-743-4 [EINECS]
Atracurii besilas [Latin]
atracurium besilate [INN_en]
atracurium besylate [USP]
Atracurium Besylate Cisatracurium
More...

Validated by Experts, Validated by Users, Non-Validated, Removed by Users

A7604_SIGMA [DBID]
D00758 [DBID]
  • Experimental Physico-chemical Properties
  • Miscellaneous
    • Safety:

      H332 312 302 319 335 315 LKT Labs [A7668]
      P261; P262 Biosynth Q-101018, Q-200865
      R20/21/22 R36/37/38 LKT Labs [A7668]
      Xn Xi LKT Labs [A7668]
    • Bio Activity:

      Atracurium Besylate is a neuromuscular blocking agent with ED95 of 0.2 mg/kg. MedChem Express http://www.medchemexpress.com/flubendazole.html, HY-B0292A
      Atracurium Besylate is a neuromuscular blocking agent with ED95 of 0.2 mg/kg. ;Target: nAChRAtracurium besylate is a neuromuscular-blocking drug or skeletal muscle relaxant in the category of non-depolarizing neuromuscular-blocking drugs, used adjunctively in anesthesia to facilitate endotracheal intubation and to provide skeletal muscle relaxation during surgery or mechanical ventilation. Atracurium is classified as an intermediate-duration non-depolarizing neuromuscular-blocking agent [1]. A 14C radiolabeled metabolism study in cats confirmed the lack of hepatic or renal involvement in the metabolism of atracurium: radioactivity eliminated in bile and urine was predominantly from metabolites rather than the unchanged parent drug [2]. MedChem Express HY-B0292A
      Membrane Tranporter/Ion Channel MedChem Express HY-B0292A
      Membrane Tranporter/Ion Channel; Neuronal Signaling; MedChem Express HY-B0292A
      nAChR MedChem Express HY-B0292A

Predicted data is generated using the ACD/Labs Percepta Platform - PhysChem Module

No predicted properties have been calculated for this compound.

Click to predict properties on the Chemicalize site





Feedback Form